Confirmatory factor analysis results
| Construct and items | Code | λ | α | CR | AVE |
|---|---|---|---|---|---|
| Transparency in pharmaceutical procurement (TRANS) | 0.766 | 0.912 | 0.675 | ||
| TRAS1 | 0.754 | |||
| TRAS2 | 0.802 | |||
| TRAS3 | 0.850 | |||
| TRAS4 | 0.875 | |||
| TRAS5 | 0.821 | |||
| Accountability in pharmaceutical procurement (ACC) | 0.853 | 0.914 | 0.680 | ||
| ACC1 | 0.820 | |||
| ACC2 | 0.766 | |||
| ACC3 | 0.830 | |||
| ACC4 | 0.874 | |||
| ACC5 | 0.831 | |||
| Perceived capabilities of e-procurement system (EPRT) | 0.807 | 0.911 | 0.674 | ||
| EPRT1 | 0.842 | |||
| EPRT2 | 0.925 | |||
| EPRT3 | 0.795 | |||
| EPRT4 | 0.709 | |||
| EPRT5 | 0.820 | |||
| Extent corrupt practices in pharmaceutical procurement (CRPT) | 0.766 | 0.896 | 0.636 | ||
| CRPT1 | 0.700 | |||
| CRPT2 | 0.841 | |||
| CRPT3 | 0.899 | |||
| CRPT4 | 0.747 | |||
| CRPT5 | 0.784 |
| Construct and items | Code | λ | α | CR | AVE |
|---|---|---|---|---|---|
| 0.766 | 0.912 | 0.675 | |||
General procurement notes are readily available to all suppliers | TRAS1 | 0.754 | |||
Suppliers are given equal chances to participate in bidding process | TRAS2 | 0.802 | |||
Tender notices are publicly available to all pharmaceutical suppliers | TRAS3 | 0.850 | |||
PE carries public bid opening immediately after submission deadline | TRAS4 | 0.875 | |||
PE ensures competitive bidding in pharmaceutical procurement | TRAS5 | 0.821 | |||
| 0.853 | 0.914 | 0.680 | |||
PE comply with pharmaceutical procurement laws and guidelines | ACC1 | 0.820 | |||
PE have robust internal controls and transparency mechanisms | ACC2 | 0.766 | |||
Officials accept liability to sanctions resulted from corrupt practices | ACC3 | 0.830 | |||
PE has clear roles for all stakeholders involved in the procurement | ACC4 | 0.874 | |||
PE have efficient procedures for reporting procurement malpractices | ACC5 | 0.831 | |||
| 0.807 | 0.911 | 0.674 | |||
Efficient monitoring of pharmaceutical procurement process | EPRT1 | 0.842 | |||
Increased transparency in pharmaceutical bidding process | EPRT2 | 0.925 | |||
Robust managerial control and audit of procurement process | EPRT3 | 0.795 | |||
Reduction of falsifications and alternation of facts | EPRT4 | 0.709 | |||
Reduced collusion and bid-rigging practices | EPRT5 | 0.820 | |||
| 0.766 | 0.896 | 0.636 | |||
Informal payments (bribery) to gain favouritism in bidding process | CRPT1 | 0.700 | |||
False recording, alteration and misrepresentation of information | CRPT2 | 0.841 | |||
Illicit payment to buyers in return of favouring award of contract | CRPT3 | 0.899 | |||
Embezzlement of budget allocated for pharmaceutical products | CRPT4 | 0.747 | |||
Collusion amongst bidders to determine the winning bidder | CRPT5 | 0.784 |
Source(s): Table by authors
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.